InvestorsHub Logo
Followers 18
Posts 1681
Boards Moderated 0
Alias Born 09/10/2014

Re: None

Saturday, 06/11/2016 8:03:24 AM

Saturday, June 11, 2016 8:03:24 AM

Post# of 701760

Who Runs Washington? The Long Reach Of Big Pharma
By Tony Cartalucci | New Eastern Outlook | June 4, 2016

http://www.mintpressnews.com/runs-washington-long-reach-big-pharma/216943/?utm_content=buffer3af82&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

"Leaked diplomatic letters sent from Colombia’s Embassy in Washington describe how a staffer with the Senate Finance Committee, which is led by Sen. Orrin Hatch, R-Utah, warned of repercussions if Colombia moves forward on approving the cheaper, generic form of a cancer drug."

"The repercussions included threats to derail the $450 million “Peace Colombia” initiative aimed at ending decades of fighting in the South American nation that has claimed nearly a quarter of a million lives."

"What is perhaps most appalling about this most recent episode is that Novartis’ “patent” is for a drug developed using public funding over several decades through the United States National Institutes of Health (NIH).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News